Osaic Holdings
ALXN

Osaic Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History

Osaic Holdings’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2
Closed -$2K – 6545
2020
Q2 		$2K Sell
2
-4
-67% -$425 ﹤0.01% 5871
2020
Q1 		$1K Buy
+6
New +$589 ﹤0.01% 5997

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Osaic Holdings's ALXN Position: Q3 2021 in Review

Osaic Holdings sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 10,157 shares — an estimated $1.86M sold.

Osaic Holdings first reported a position in ALXN in Q1 2020 and held it in 6 quarters. The position peaked at $4.19M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Osaic Holdings reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Osaic Holdings sold 10,157 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.86M.
  • Osaic Holdings first reported a position in Alexion Pharmaceuticals in Q1 2020 and held it in 6 quarters.
  • Osaic Holdings's Alexion Pharmaceuticals position peaked at $4.19M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Osaic Holdings's 13F filing for Q3 2021, filed 5 Nov 2021.